Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand

Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand

Upworthy

Published

Maker of ‘miracle’ weight loss drugs Ozempic and Wegovy, Novo Nordisk A/S NVO has announced the acquisition of three fill-finish sites from Novo Holdings A/S for $11 billion. The acquisition is part of a larger deal where Novo Holdings is set to acquire Catalent, Inc. CTLT, a global contract…

#novoholdingsas #novoholdings #catalentinc #ctlt #novonordisks #anagni #belgium #bloomington #indiana #novonordisk

Full Article